Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-1128-2021Class II

13C-Spirulina Gastric Emptying Breath Test (GEBT) -

Cairn Diagnostics / initiated 2021-01-08 / Terminated

Cairn Diagnostics began a recall of 13C-Spirulina Gastric Emptying Breath Test (GEBT) - Product Usage: intended for use in the measurement of the rate of gastric emptying of solids and as an aid... on . FDA classified it as Class II and gives the reason as "Potential for false negative diagnosis of gastroparesis. Certain GEBT kits containing 13C-Spirulina elicit unusually high 13CO2-excretion rates". As of , the recall status on record is Terminated.

Recall record

Recall number
Z-1128-2021
Classification
Class II
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Cairn Diagnostics
Product
13C-Spirulina Gastric Emptying Breath Test (GEBT) - Product Usage: intended for use in the measurement of the rate of gastric emptying of solids and as an aid in the diagnosis of delayed gastric emptying (gastroparesis) in adult humans who are symptomatic for gastroparesis.
Product code
PGE Gastric Emptying Breath Test
Reason for recall
Potential for false negative diagnosis of gastroparesis. Certain GEBT kits containing 13C-Spirulina elicit unusually high 13CO2-excretion rates
FDA root cause
Under Investigation by firm
Action
The firm initiated the recall by telephone or email, followed with a telephone call on 01/08/2021. Commercial clients have been instructed not to use GEBT kits and that Cairn will follow up with a recall notice with full instructions on what to do with kits.
Quantity in commerce
103 kits
Distribution
US Nationwide distribution in the states of GA, NY, MI, CA, KS, NC.
Product codes and lots
Lot Codes: K021-021R, K021-022

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-1128-2021
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-1128-2021Class IITerminatedVoluntary: Firm initiated